ALEXANDRIA, Va., July 9 -- United States Patent no. 12,350,336, issued on July 8, was assigned to City University of Hong Kong (Kowloon, Hong Kong).
"Photo-activatable compound, its preparation and therapeutic use" was invented by Chun-Sing Lee (Kowloon, Hong Kong), Shengliang Li (Kowloon, Hong Kong), Yafang Xiao (Kowloon, Hong Kong) and Wencheng Chen (Kowloon, Hong Kong).
According to the abstract* released by the U.S. Patent & Trademark Office: "A compound including a general formula of D-L-A particularly with the structure of Formula (A). A nanoparticle of the compound of the present invention. A pharmaceutical composition including the compound of the present invention as an active ingredient and a pharmaceutically acceptable carrier....